ALFA Filings
Every announcement, straight from the exchange
Every Concord Drugs debt & borrowing announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
Concord Drugs Limited confirmed it does not qualify as a 'Large Corporate' as of March 31, 2026, under SEBI's debt issuance framework. Consequently, mandatory borrowing requirements through debt securities are not applicable for FY 2025-26.
Concord Drugs Ltd has submitted its initial disclosure under the SEBI Large Corporate framework for the financial year ending March 31, 2026. The company reported outstanding borrowings of ₹10.00 Crore. This filing confirms compliance with debt-raising norms mandated for entities identified as Large Corporates.